Updates are available Correction dated 2021-01-19
Click to view Correction: https://doi.org/10.1038/s41586-020-03098-3
-
Authors
Mulligan, Mark J.
Lyke, Kirsten E.
Kitchin, Nicholas
Absalon, Judith https://orcid.org/0000-0002-1091-520X
Gurtman, Alejandra
Lockhart, Stephen
Neuzil, Kathleen
Raabe, Vanessa
Bailey, Ruth
Swanson, Kena A. https://orcid.org/0000-0002-3389-8414
Li, Ping
Koury, Kenneth
Kalina, Warren
Cooper, David
Fontes-Garfias, Camila
Shi, Pei-Yong https://orcid.org/0000-0001-5553-1616
Türeci, Özlem
Tompkins, Kristin R.
Walsh, Edward E.
Frenck, Robert
Falsey, Ann R.
Dormitzer, Philip R.
Gruber, William C.
Şahin, Uğur https://orcid.org/0000-0003-0363-1564
Jansen, Kathrin U.
- License Information
-
More Information
Article History
Received: 29 June 2020
Accepted: 4 August 2020
First Online: 12 August 2020
Change Date: 19 January 2021
Change Type: Correction
Change Details: A Correction to this paper has been published: https://doi.org/10.1038/s41586-020-03098-3.
Competing interests
: N.K., J.A., A.G., S.L., R.B., K.A.S., P.L., K.K., W.K., D.C., K.R.T., P.R.D., W.C.G. and K.U.J. are employees of Pfizer and may hold stock options. U.Ş. and Ö.T. are stock owners, management board members and employees at BioNTech and are inventors on patents and patent applications related to RNA technology. M.J.M., K.E.L., K.N., E.E.W., A.R.F., R.F. and V.R. received compensation from Pfizer for their role as study investigators. C.F.-G. and P.-Y.S. received compensation from Pfizer to perform the neutralization assay.
Free to read: This content has been made available to all.
